Gene transfer of connexin43 into skeletal muscle.
Cellular cardiomyoplasty using skeletal myoblasts may be beneficial for infarct repair. One drawback to skeletal muscle cells is their lack of gap junction expression after differentiation, thus preventing electrical coupling to host cardiomyocytes. We sought to overexpress the gap junction protein connexin43 (Cx43) in differentiated skeletal myotubes, using retroviral, adenoviral, and plasmid-mediated gene transfer. All strategies resulted in overexpression of Cx43 in cultured myotubes, but expression of Cx43 from constitutive viral promoters caused significant death upon differentiation. Dye transfer studies showed that surviving myotubes contained functional gap junctions, however. Retrovirally transfected myoblasts did not express Cx43 after grafting into the heart, possibly due to promoter silencing. Adenovirally transfected myoblasts expressed abundant Cx43 after forming myotubes in cardiac grafts, but grafts showed signs of injury at 1 week and had died by 2 weeks. Interestingly, transfection of already differentiated myotubes with adenoviral Cx43 was nontoxic, implying a window of vulnerability during differentiation. To test this hypothesis, Cx43 was expressed from the muscle creatine kinase (MCK) promoter, which is active only after myocyte differentiation. The MCK promoter resulted in high levels of Cx43 expression in differentiated myotubes but did not cause cell death during differentiation. MCK-Cx43-transfected myoblasts formed viable cardiac grafts and, in some cases, Cx43-expressing myotubes were in close apposition to host cardiomyocytes, possibly allowing electrical coupling. Thus, high levels of Cx43 during skeletal muscle differentiation cause cell death. When, however, expression of Cx43 is delayed until after differentiation, using the MCK promoter, myotubes are viable and express gap junction proteins after grafting in the heart. This strategy may permit electrical coupling of skeletal and cardiac muscle for cardiac repair.
Reinecke
Hans
H
Department of Pathology, University of Washington, Seattle, 98195, USA. hreineck@u.washington.edu
Minami
Elina
E
Virag
Jitka I
JI
Murry
Charles E
CE
D000256:Adenoviridae / Q000235:genetics; D000818:Animals; D002454:Cell Differentiation; D018031:Connexin 43 / Q000032:analysis / Q000096:biosynthesis / Q000235:genetics*; D003402:Creatine Kinase / Q000235:genetics; D052283:Creatine Kinase, MM Form; D017629:Gap Junctions / Q000235:genetics / Q000378:metabolism; D006801:Humans; D007527:Isoenzymes / Q000235:genetics; D051379:Mice; D018485:Muscle Fibers, Skeletal / Q000276:immunology / Q000378:metabolism; D018482:Muscle, Skeletal / Q000276:immunology / Q000378:metabolism; D032448:Myoblasts, Skeletal / Q000276:immunology / Q000378:metabolism* / Q000637:transplantation; D009206:Myocardium / Q000276:immunology / Q000378:metabolism; D011401:Promoter Regions, Genetic / Q000235:genetics; D051381:Rats; D014162:Transfection
D018031:Connexin 43; D007527:Isoenzymes; D003402:Creatine Kinase; D052283:Creatine Kinase, MM Form